Free Trial

BioLife Solutions (BLFS) Earnings Date, Estimates & Call Transcripts

BioLife Solutions logo
$38.61 0.00 (0.00%)
As of 11/6/2026

BioLife Solutions Earnings Summary

BioLife Solutions released Q2 2026 earnings on August 6, 2026, reporting an EPS of $0.91, which beat the consensus estimate of $0.03 by $0.88. Quarterly revenue was reported to be $28.47 million, above analysts' expectations of $27.80 million. With a trailing EPS of $1.16 and a P/E Ratio of 33.28, BioLife Solutions' earnings are expected to grow 433.33% next year, from $0.03 to $0.16 per share.

Latest Q2
Earnings Date
Aug. 6Estimated
Consensus EPS
(Aug. 6)
$0.03
Actual EPS
(Aug. 6)
$0.91 Beat By $0.88
Actual Revenue
(Aug. 6)
$28.47M

Q2 2026 Earnings Resources

Get BioLife Solutions Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioLife Solutions and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

BLFS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BLFS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioLife Solutions Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Revenue GuidanceRevenue Estimate at Guidance
Q1 20262-$0.02$0.01-$0.01
Q2 20262-$0.01$0.02$0.01
Q3 20262$0.01$0.03$0.02
Q4 20262$0.01$0.04$0.03
FY 20268-$0.01$0.10$0.05
Q1 20271$0.03$0.03$0.03
Q2 20271$0.03$0.03$0.03
Q3 20271$0.05$0.05$0.05
Q4 20271$0.05$0.05$0.05
FY 20274$0.16$0.16$0.16

BioLife Solutions Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026$0.0313$0.91+$0.8788$0.91$27.80M$28.47M
5/7/2026Q1 2026$0.01$0.04+$0.03$0.02$25.66M$27.50M
8/7/2025Q2 2025-$0.02-$0.33 -$0.31-$0.33$23.71M$25.42M
5/8/2025Q1 2025-$0.03$0.04+$0.07-$0.01$22.22M$23.94M
3/3/2025Q4 2024-$0.06$0.26+$0.32$0.26$21.73M$22.71M

BioLife Solutions Earnings - Frequently Asked Questions

BioLife Solutions (NASDAQ:BLFS) last announced its quarterly earning data on Thursday, August 6, 2026. Learn more on BLFS's earnings history.

In the previous quarter, BioLife Solutions (NASDAQ:BLFS) reported $0.91 earnings per share (EPS) to beat the analysts' consensus estimate of $0.03 by $0.88. Learn more on analysts' earnings estimate vs. BLFS's actual earnings.

BioLife Solutions' earnings report can be found in their filing with the SEC.
View SEC filing

BioLife Solutions (NASDAQ:BLFS) has a recorded annual revenue of $106.69 million.

BioLife Solutions (NASDAQ:BLFS) has a recorded net income of -$4.59 million. BLFS has generated $1.16 earnings per share over the last four quarters.

BioLife Solutions (NASDAQ:BLFS) has a trailing price-to-earnings ratio of 33.28 and a forward price-to-earnings ratio of 241.31.

BioLife Solutions' earnings are expected to grow from $0.03 per share to $0.16 per share in the next year, which is a 433.33% increase.


Earnings data for NASDAQ:BLFS is sourced from Fiscal.ai, with the most recent quarter reported on 8/6/2026. New results are added as companies report their earnings.
From Our Partners